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Viruses are tiny particles that cannot replicate – or survive for very long – outside 
the cells of their host organism; yet they remain an ongoing risk to our health 
and our eye health.
Globally, viral infections of the eye are common. They are a significant cause of acute red eye and visual loss. Any part of the eye and adnexa – from 
the eyelids to the retina and optic nerve – can be affected 
by viral disease. Some ocular viral infections, such as viral 
conjunctivitis due to adenovirus or influenza virus, are 
short lived, with limited ocular complications. However, 
other viral infections can cause serious complications, 
such as corneal scarring from stromal keratitis due 
to herpes simplex virus (HSV) or retinal detachment 
resulting from cytomegalovirus (CMV) retinitis. 
Certain viral eye diseases demonstrate clear clinical 
signs that enable diagnosis (such as the dendritic 
ulcers due to HSV or the unilateral trigeminal 
nerve distribution of herpes zoster ophthalmicus). 
In other cases (for example follicular conjunctivitis 
or uveitis), a variety of different viral infections 
may be responsible for the same clinical signs. 
Making a specific diagnosis can therefore be very 
challenging.
Antibiotics are not effective against viruses, but 
evidence-based anti-viral treatments exist for several 
viral infections, including herpes simplex (HSV), varicella 
zoster (VZV), cytomegalovirus (CMV) and human 
immune-deficiency virus (HIV). 
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What you will learn
In this issue, we present reviews of eye disease due to 
herpes simplex and herpes zoster. These are both DNA 
viruses (see p. 67) and tend to lie dormant in nerve 
ganglia. Adenovirus is another DNA virus; it usually causes 
an infectious follicular conjunctivitis. There are also 
review articles on viral diseases which have come into 
more prominence in the last two to three decades: HIV, 
CMV and, more recently, Ebola and Zika. Finally, we have 
included an article that reviews our current understanding 
of the available treatments for ocular viral infections.
The aim of this issue is to present an overview of the 
common and important ocular viral infections, how a 
clinical diagnosis can be made, and the steps that can be 
taken to prevent and treat ocular viral infections in order 
to reduce eye disease and visual loss. If you find it useful, 
please share it with your colleagues and team members. 
About this issue
Viral infections of the eye can affect any part of the 
eye and surrounding tissues; they are a significant 
cause of acute red eye and visual loss. In this issue, 
we present an overview of the most common and 
important ocular viral infections, including diagnosis, 
management and prevention. 
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Figure 1 Electron micrograph image of several herpes 
simplex viruses, showing the lipid envelopes (studded 
with glycoprotein ’spikes’). Inside each envelope is the 
nucleocapsid, which houses the viral DNA.
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How viruses work 
Viruses are very small infectious agents 
(Figure 2). They consist of:  
• Genetic material (RNA or DNA) 
• A protein coat (the capsid) that 
surrounds or protects the genetic 
material 
• A lipid envelope around the capsid, 
studded with unique surface proteins 
(glycoproteins). Some viruses do not 
have an envelope. 
Viruses are very simple organisms 
and can only multiply within the living 
cells of a host organism, such as a 
human being. A virus will enter the cell 
and trick it into making copies of the 
virus until the cell bursts and releases 
the copies, often destroying the cell in 
the process.
The viruses – known as viral particles or 
virions when outside a cell – can then 
invade other cells or be transmitted to 
another host. The main mechanisms of 
transmission are: 
• Exchange of bodily fluids (e.g., via 
blood transfusion, kissing or sexual 
intercourse)
• Inhalation of airborne viral particles 
(after an infected person coughs or 
sneezes)
• Transfer of viral particles from 
contaminated surfaces to the 
eyes, nose or mouth, usually via 
the hands. Surfaces – including 
ophthalmic equipment – can become 
contaminated when an infected 
person coughs or sneezes, or touches 
the surface after touching their nose, 
mouth or eyes
• Contaminated surgical instruments 
that come into contact with body 
tissues and fluids during surgery.
Viruses cause disease in two ways: 
• The direct action of the virus on 
cells. For example, herpes simplex 
dendritic ulcer.   
• The body’s immune response to the 
virus and/or virus-infected cells. For 
example, herpes simplex disciform 
endotheliitis (p. 69).  
The immune response 
The body’s immune system responds 
to a viral infection by making specific 
antibodies (the immunoglobulins IgM and 
IgG) designed to bind either to the unique 
viral surface proteins, or to viral fragments 
that remain outside the host cell. The 
antibody can help to mark the virus or 
infected cell for destruction by the body’s 
T lymphocyte cells (also known as killer 
T cells). Once the viral infection has been 
halted, the memory to make antibodies 
remains in the immune system of the 
host, which allows the immune system to 
recognise the same virus immediately and 
act to stop a new infection.  
Immunisation takes advantage of 
this fact. It involves exposing the host 
to a non-pathogenic version of the virus: 
so that the person doesn’t become ill, 
but the immune system produces 
antibodies against future exposure 
to a pathogenic version of the virus. 
This approach is used successfully with 
some viruses, such as measles and 
rubella, which are considered ‘stable’. 
However, with other viruses, such as 
HIV, the surface proteins are continually 
changing, so that antibodies do not 
work effectively.  The immune system 
struggles to fight such virus infections 
and immunisation is therefore 
problematic. 
Prevention 
Some viral infections can also be 
prevented by reducing transmission 
between people. Avoiding unprotected 
sexual intercourse reduces the 
risk of transmission of human 
immunodeficiency virus (HIV) and 
herpes simplex virus 1 (HSV-1). Regular 
and effective handwashing helps to 
prevent the transmission of some 
viruses e.g., adenovirus. 
In a hospital or clinic setting, you can 
reduce transmission between doctor and 
patient, and from patient to patient, by 
practising good hygiene. This includes: 
• Close attention to handwashing 
(scrubbing)
• Cleaning of all surfaces, equipment 
and instruments using appropriate 
methods and antiviral solutions
• Wearing protective clothing such as 
gloves and, in some circumstances, 
a mask. 
Editorial team
Figure 2 Simplified diagram of the herpes 
simplex virus. 
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